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Introduction: Binge Eating Disorders is a clinical syndrome recently coded as an autonomous diagnosis in DSM-5.
Individuals affected by Binge Eating Disorder (BED) show significantly lower quality of life and perceived health and
higher psychological distress compared to the non-BED obese population. BED treatment is complex due to clinical
and psychological reasons but also to high drop-out and poor stability of achieved goals. The purpose of this review is
to explore the available data on this topic, outlining the state-of-the-art on both diagnostic issues and most effective
treatment strategies.
Methods: We identified studies published in the last 6 years searching the MeSH Term “binge eating disorder”, with
specific regard to classification, diagnosis and treatment, in major computerized literature databases including: Medline,
PubMed, PsychINFO and Science Direct.
Results: A total of 233 studies were found and, among them, 71 were selected and included in the review.
Review: Although Binge Eating Disorder diagnostic criteria showed empirical consistency, core psychopathology traits
should be taken into account to address treatment strategies. The available body of evidence shows psychological
treatments as first line interventions, even if their efficacy on weight loss needs further exploration. Behavioral and
self-help interventions evidenced some efficacy in patients with lower psychopathological features. Pharmacological
treatment plays an important role, but data are still limited by small samples and short follow-up times. The role of
bariatric surgery, a recommended treatment for obesity that is often required also by patients with Binge Eating
Disorder, deserves more specific studies. Combining different interventions at the same time does not add significant
advantages, planning sequential treatments, with more specific interventions for non-responders, seems to be a
more promising strategy.
Conclusions: Despite its recent inclusion in DSM-5 as an autonomous disease, BED diagnosis and treatment strategies
deserve further deepening. A multidisciplinary and stepped-care treatment appears as a promising management
strategy. Longer and more structured follow-up studies are required, in order to enlighten long term outcomes
and to overcome the high dropout rates affecting current studies.
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The fifth edition of Diagnostic and Statistical Manual of
Mental Disorders (DSM-5) [1] published in May 2013,
codes for the first time Binge Eating Disorder (BED) as
an autonomous Eating Disorder (ED), while before it
was listed as an Eating Disorder not Otherwise Specified
(EDNOS) needing future definition. This disease is of
particular interest for its frequency in primary care, its* Correspondence: federico.amianto@unito.it
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unless otherwise stated.link with obesity and its medical and psychiatric comor-
bidities, leading to high socio-economic impact due to
reduced quality of life and increased health service
utilization [2,3]. It is in fact a relatively common dis-
order, with an estimated lifetime prevalence in general
population around 1.4% [4]. However, this estimate sub-
stantially increases among obese individuals with no
marked gender differences [4]. Prevalence is likely to in-
crease, especially because of the rising incidence that
both obesity and EDs show worldwide rather than for the
widening of diagnostic criteria introduced in DSM-5 [5,6].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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adulthood, recent studies furthermore suggest a lower
age of onset than that previously assumed [4]. Increasing
evidence is emerging that it already occurs in adoles-
cence and childhood, with an average age of onset ran-
ging from late teens to early 20s and a mean persistence
of 4.3 years [4]. An earlier onset of bingeing seems to
predict worse outcome and to require more complex in-
terventions [7]. In addition, although there is still a wide
debate on the clinical stability of such a diagnosis, data
showed that it tends to be a stable syndrome, with rela-
tive stability of binge eating patterns [8] and lower cross-
over rates than other EDs [9].
The clinical importance of BED is also related to its
frequent comorbidity with obesity as well as complica-
tions of overweight [4] and with psychiatric symptoms
like depression and anxiety, frequently linked to exces-
sive concerns about food, body shape and weight
[10,11]. Moreover, like other EDs, BED patients show
relevant alexithymia and deficit in emotional identifica-
tion and regulation [12,13] and high interpersonal prob-
lems [14,15]. Personality disorders are also frequently
diagnosed among BED patients and mood disorders
and substance abuse are frequent comorbidities [4,16],
eventually related to more severe psychopathology and
worse prognosis [17-19]. These correlations are so rele-
vant that these comorbidities have been proposed as
markers of major severity, rather than just associated
conditions [19].
Also due to these relevant comorbidities, perceived
quality of life and health are significantly lower in BED
than in the non-BED obese population, with great ex-
pression of depressive and negative feelings, disinhibition
and anger [11,13,20]. Low mood and negative feelings
seem to be related to severe eating impulsiveness, lead-
ing to significant psychopathological impairment even in
presence of a limited food assumption [13,18]. Eating
impulsiveness itself has been related to greater physical
discomfort and worse quality of life, independently from
Body Mass Index (BMI) and objective functional impair-
ment, and it is also consequently related to higher treat-
ment seeking [15,20,21].
The clinical relevance of BED, here underlined, high-
lights the importance of identifying appropriate and evi-
dence based treatment strategies, in order to prevent
this disorder to become chronic and complicated [4]. It
is the purpose of this review to explore the state-of-the-
art on this topic, exposing current evidence on diagnosis
and treatment.
Methods
We aimed to systematically identify and synthesize the
recent evidences about BED diagnostic category with
regards to its recent addition as an autonomous diseasein DSM-5, with a focus on its clinical features, psycho-
pathological correlates and treatment evidences. In rela-
tion to these issues, we summarized the principal
findings published from January 2008 to May 2014 about
this topic. We choose this time frame because the first
articles claiming BED inclusion in DSM-5 in online
databases date back this year [22]. We identified rele-
vant studies searching the MeSH Term “binge eating
disorder”, with specific regard to classification, diagnosis
and treatment, in major computerized literature data-
bases including: Medline, PubMed, PsychINFO and
Science Direct. We focused on clinical studies about
adult population, excluding studies about children and
young adults. We also excluded from the evaluation case
reports and case series studies.
Any experimental research that is reported in the
manuscript has been performed with the approval of an
appropriate ethics committee. Research carried out on
humans are in compliance with the Helsinki Declaration,
and experimental research on animals follows inter-
nationally recognized guidelines.
Results
A total of 233 studies were found and 71 were included
in this review according to the aforementioned criteria
(see Table 1 for a summary). To enhance the specificity
of our search, we considered only studies based on the
specific diagnosis of BED. We therefore excluded 64
studies pertaining to mixed ED samples, non-purging
bulimia nervosa, atypical EDs, EDNOS, if not including
BED, physical comorbidities of binge eating and obesity
or the ICD-10 category “overeating associated with other
psychiatric condition”. We also excluded 24 studies re-
ferring to sub-threshold BED, a clinical category meant
to be redefined by the application of diagnostic criteria
for EDs in DSM-5.
Because of their limited usefulness in clinical practice,
they were excluded 30 studies referring to neurobio-
logical, neurocognitive and endocrine correlates of BED,
12 studies referring to laboratory tests and drugs not
available in commerce, and 10 studies about diagnostic
test validity. Twelve more excluded studies concerned
secondary descriptive characteristics of BED, and 5 were
about binge eating specificities among ethnic minorities.
Five studies were not accessible to reading because writ-
ten in languages different from English or Italian.
Review
Diagnostic issues and pathological features
According to the biopsychosocial model of mental dis-
eases a comprehensive assessment and understanding of
psychopathological mechanisms, maintenance factors,
and dysfunctional areas of psychiatric illnesses are useful
to support and address therapeutic interventions [23].
Table 1 Summary of studies included in the review*
Thematic area Article n. Authors Patients n./Articles n. Duration
(months)
Drop-out rates Main results Type of study
Diagnostic issues and
pathological features
23 Bautista-Diaz et al.,
2012 [21]
70 obese women
(35 BED; 35 non BED)
——— ——— Higher body dissatisfaction and stronger
influence of socio-cultural factors on
eating psychopathology (at self-administered




78 obese with BED ——— ——— Mean weight gain of 15.1 pounds during
the year before treatment in BED patients
(structured interviews + self-administered
test). Weight change associated with more






84 obese with BED ——— ——— Higher interpersonal problems (at interpersonal
circumplex structural summary method)
observed in in BED patients and associated




80 BED ——— ——— Among BED patients, 27.5% refer suicide
ideation and 12.5% previous attempts of
suicide (self-administered tests). Alexithymia





92 women with BED
(full-criteria and
subthreshold)
6 treatment 10.6 – 30.8% Participants to an internet self-help program
split by cluster analyses into pure dietary
subtype (71.7%) and dietary-negative affect
subtype (28.3%) (clinical interview +
self-administered tests). Dietary-negative
affect subtype show higher frequency of
binges, more severe eating disorders, higher
tendency to act rashly in the context of
negative affect, greater sensitivity to






150 obese non BED;
150 healthy controls
——— ——— Lower mindfulness scores (Five Facet
Mindfulness Questionnaire) in BED patients
than in healthy and obese controls.
Mindfulness negatively correlated with
binge frequency, body uneasiness and




130 obese ——— ——— Presence of EDs impaired significantly
quality of life and is related to higher





326 obese with BED ——— ——— Difficulties with emotion regulation
accounted for unique variance in both















Table 1 Summary of studies included in the review* (Continued)
Grilo et al.,
2009 [27]





——— ——— Clinical overvalu of body shape and
weight present of BED and related
to significantly h levels of eating
disorder psycho logy. BED clinical
overvaluation g how higher eating
concern, shape rn, and weight
concern than o roups. This feature
warrants consid n either as a diagnostic




90 BED (52 with
overvaluation; 38
without overvaluation)
6 treatment + 12
follow-up
24% (CBT) - 31%
(BWL)
Participants rand assigned to group
CBT or BWL. Pat with overvaluation of
weight and bod pe had significantly
greater levels of sychopathology,
higher depressio lower self-esteem
(semi-structured views + clinical
measures). Over ion of shape/weight
predicts non-rem n from BED and higher







family study of BED
——— ——— Using the propo SM-5 diagnostic
criteria vs DSM- ria (clinical interview)
will likely have o minimal effect on




311 women (39 BN;
69 BED; 203 controls)
——— ——— Atypical eating ns (e.g. nibbling,
eating double m nd nocturnal eating)
more frequent a EDs (at internet
questionnaire). st consumption
associated with BMI in BED and
controls and mo quent meal





130 obese with BED ——— ——— 83% of treatme king obese BED
patients gained t in year before
treatment (struc interview + self-report
questionnaires). fferences among
weight gainers a ight maintainers/losers





22 women with BED ——— ——— During binge d 1 week of ecological
assessment) neg mood and tension
are higher and antly increased at
first binge episo hile positive mood
strongly and sig tly decreased. No
indications of ac lation of negative
mood triggering es followed by
reinforcing mec s in terms of

























































Table 1 Summary of studies included in the review* (Continued)
Ojserkis et al.,
2012 [28]




4 treatment 52.25% Patients selected from a 16-week randomized
controlled trial of BWL + individual CBT and/or
fluoxetine**. Patients with overvaluation of
weight and body shape show higher
pre-treatment scores on depression and
eating psychopathology and lower
self-esteem (self-administered tests). At
treatment termination patients with






188 EDs (71 AN, 95 BN,
122 BED)
2 follow-up 0% Although longitudinal patterns of binge
types are variable among individuals with
EDs, consistency in objective and subjective







——— ——— Social anxiety positively and significantly
related with shape and weight concerns
and binge frequency (semi structural
clinical interviews + self-report measure).
Social anxiety and self-consciousness
account for significant variance in eating,
shape and weight concerns and ED severity





51 articles ——— ——— Evidences of increased food-related impulsivity,
coupled with increased reward sensitivity, in
BED patients. BED could represent a specific





——— ——— ——— Clinical utility and validity of BED diagnostic





125 articles ——— ——— EDNOS did not differ significantly from AN
and BED on eating or general psychopathology
while BN show greater eating and general
psychopathology. Subthreshold BN or BED





13295 female twins ——— ——— Lifetime prevalence of BN and BED increased
linearly as the frequency criterion for binges
decreased. As required duration increased,






83 BN, 668 healthy
controls)
——— ——— All of the BED diagnostic criteria in DSM.IV
have predictive value. Eating alone because
embarrassed and feeling disgusted performed
as the best inclusion and exclusion criteria,
respectively. Eating when not hungry and
eating alone because embarrassed are the














Table 1 Summary of studies included in the review* (Continued)
Wolfe et al.,
2009 [33]
33 articles ——— ——— Majority of binge episodes typically occur in
less than 2 h, with size variability across BN
and BED but a clinical importance likely
related to objective food intake and an
increased consumption of carbohydrates
and fats. Loss of control is a core feature
associated with higher depression, higher
body dissatisfaction and poorer related
quality of life. Negative affect is the most
widely reported binge antecedent.
Literature review
Global treatment 7 Brambilla et al.,
2009 [35]
30 (+5 dropped-out)
BED (3 groups of
10 patients)
6 treatment 14% Group 1: 1700-kcal diet + CBT + sertraline
(50–150 mg/day) + topiramate
(25–150 mg/day); group 2: diet + CBT +
sertraline; group 3: nutritional counselling +
CBT. Clinical interview and self-administered
tests. Binge frequency and body weight
decrease only in group 1. Group 2 improved





212 BED 5 treatment 14% Higher social embedding and higher
openness predict better outcomes at CBT
(self-administered tests). Higher depression,






78 BED 4 treatment;
6 follow-up
36% Low self-esteem predicts premature treatment
termination. Low self-esteem experiences, low
global alliance, low mastery and clarification
experiences predict dropout in patients who






125 obese with BED
(45 CBT; 45 BWL;
35 CBT + BWL)
4 treatment + 12
follow-up
24 - 40% At 12-month, binge-eating remission rates
of 51% (CBT), 36% (BWL), 40% (CBT + BWL)
and mean BMI losses of −0.9%(CBT), −2.1%
(BWL) and 1.5% (CBT + BWL). Overall significant
percent BMI loss in CBT + BWL attributable to
BWL. Binge-eating remission associated with





90 obese with BED
(45 CBT; 45 BWL)
4 treatment + 12
follow-up
24 - 40% Rapid response (≥70% binge reduction in
4 weeks) is present in 57% of participants
(67% CBT, 47% BWL) and predicts greater
improvements across outcomes. CBT patients
did comparably well regardless of rapid
response in binge eating and eating
psychopathology but not in weight loss. BWL
patients without rapid response failed to
improve further but those with rapid response
show greater reductions in binge frequency,















Table 1 Summary of studies included in the review* (Continued)
Vocks et al.,
2010 [36]
38 articles (1973 patients) ——— ——— Psychotherapy and structured self-help, mainly
CBT, recommended as first line treatments for
BED. Moderately positive effect on binges and
depressive symptoms of pharmacotherapy,
manly SSRI. Weight-loss treatments demonstrated
moderate binge reduction at uncontrolled studies.
Combination treatments not show higher effects
than single-treatment. Only weight-loss treatment









2.5 treatment 34.6% Participant randomized to 3 group manual-based
CBT (therapist-led, therapist-assisted, self-help).
Decrease in binges during treatment predicts
clinical outcome. Participants with a 15%







24 Balestieri et al.,
2013 [54]
98 patients (54 BED;
44 EDNOS)
2.5 weekly + 8
monthly sessions
6.1% after
10 weeks, − 39.6%
at 8 months
Psychoeducational intervention of 10 weekly
group sessions. Post-treatment patients who
maintained an ED were asked to participate
to 2 fortnightly sessions +monthly sessions
for 8 months. At 10 weeks 30.6% of patients
remitted and all patients showed significant
improvements on binge frequency, BMI,
bulimic traits, body dissatisfaction, anxiety,
depression and alexithymia. At 8 months
41% recovered from ED, with further




74 women with BED
(37 Group 1;
37 Group 2)
6 treatment + 6
follow-up
19 - 24,3% Group 1: 6 months online CBT + 6 months
follow-up; group 2: 6 months waiting
list + 6 months online CBT. Regular e-mail
contact with a coach during intervention.
After treatment binge eating, drive for
thinness, body dissatisfaction and
interoceptive awareness significantly
improved. Binge episodes, overall eating
symptoms and hunger also decreased.
Improvements maintained at follow-up.






(of which 283 BED)
6 treatment + 72
follow-up
0% Patients evaluated with clinical interview
undergo 6 months individual CBT. At 6-year
follow-up, overall recovery rate was 59.2%
for BED and 77.2% for subthreshold BED.
Crossover rates (DSM-IV) of 8.8% from BED
to BN and 10.9% from BN to BED. Relapse
rates of 11.4% for BED and 12.1% for
subthreshold-BED. Among relapsed patients
who changed diagnosis 18.1% of BN
developed BED, 18.7% of BED developed
















Table 1 Summary of studies included in the review* (Continued)
Compare et al.,
2013 [46]
189 obese with BED
(63 EFT; 63 CT; 63 DT)
5 treatment + 6
follow-up
27% DT vs. 12.7%
EFT vs. 0% CT
Patients randomized to Emotionally Focused
Therapy (EFT), Dietary Counseling (DC), and
Combined Treatment (CT). DC showed
higher dropout rate. Body weight decreased
in all three groups. Eating symptomatology
decreased with CT and EFT. At follow-up,
71% of CT patients and 46% in EFT had
subthreshold eating impulsivity, whereas no








20 weekly group sessions + 3 individual
sessions of CBT or IPT. Long-term BED
recovery rates of 52.0% for CBT and 76.7%
for IPT. Recovery from subclinical BED 72.0%
for CBT and 83.9% for IPT (non-significant




27 articles ——— ——— Individual and group CBT associated with
higher binge abstinence rates compared with
supportive therapy and BWL. CBT guided
self-help have superior outcomes than BWL
guided self-help and comparable to IPT in
patients with low additional pathology. IPT is
the only treatment with comparable long-term
outcomes to CBT. Psychodynamic IPT
(additional focus on cyclical relational patterns
and negative internalizations) comparable to
CBT both post-treatment and at 12-month
follow-up. DBT shows some promise as BED




24 articles (12 BN;
9 BED, 3 EDNOS)
——— ——— Literature evidenced CBT guided self-help as a
brief, cost-effective treatment for BED,
comparable with more complex interventions
and not necessarily contra-indicated for




10 women with BED
or BN
4.5 treatment 50% DBT showed positive preliminary outcomes




297 BED patients 2.5 treatment 27% Group psychoeducational intervention showed
efficacy on eating impulsivity and related
psychopathology. No significant results on
weight and depression. Higher impulsivity




50 obese with BED
(25 CBT + ED;
25 CBT + GN)
6 treatment 14% Patients randomized to CBT + low-Energy-Density
diet (CBT + ED) or CBT + General Nutrition
counseling not related to weight loss
(CBT + GN). 30% of patients achieved at least
a 5% weight loss with binge remission rates
of 55–75%. No significant differences among
treatments. Significantly better dietary
outcomes on energy density, and fruit and















Table 1 Summary of studies included in the review* (Continued)
Masson et al.,
2013 [66]
60 BED (30 treatment;
30 wait-list)
3 treatment + 6
follow-up
25% Self -help based i T manual + six 20-min
support calls. Pos atment efficacy on







80 obese with BED
(44 CBT; 36 BWL)






(CBT) - 28% (BWL)
Patients randomi o CBT or BWL group
intervention. Stro utcome improvement
during active trea nt but worsening at
follow-up, howeve h residual improvement
at 6-year follow-up tive to pretreatment
values. Comparab g-term effects between











26% mean Therapist-led vs se lp CBT-based intervention.
Binge abstinence .7% of therapist-led,
33.3% of therapist ted, 17.9% of self-help
group and 10.1% ait-list. No differences in
abstinence rates a ow-up. Therapist-led
group show more ctions in binge eating
at post treatment follow-up. Treatment
completion rates h r in therapist-led
(88.3%) and wait-li 1.2%) groups than in












7% Individual and gr CBT (clinical interview +
self-reported test ow similar long-term
response with a s icant binge reduction
and mild weight ction. Lower emotional
eating and binge ng severity predict full
recovery. Overwe during childhood, full
blown BED diagn and high emotional






(50 DBT; 51 ACGT)
5 treatment 4% DBT 33.3%
ACGT
Comparing DBT t tive comparison group
therapy (ACGT), p ts with Avoidant
Personality Disord r earlier onset of












Group DBT comp to ACGT show
significantly lowe pout rate.
Post-treatment bi abstinence and
reduction achieve ore quickly with











Rapid responders ecially to group DBT,
show higher bing stinence at end of
treatment and 1 follow-up and also






























































(40 CBT-L; 36 CBT-S)
2-4 treatment;
12 follow-up
14% (CBT-S) - 35%
(CBT-L)
Comparing long an short term CBT - 16
sessions (CBT-L) vs essions (CBT-S) – both
treatments show si ificant binge reductions.
At the end of activ reatment, but not at
follow-up, better o omes in CBT-L.
Treatment efficacy rapid responders
and individuals wit igh dietary negative




et al., 2010 [60]
123 patients (59 BED;





16.3% CBT based guided f-help (CBT-gsh,
8 sessions) vs treat nt as usual (TAU,
non-dietary primar are management).
At follow-up, CBT-g show greater binge










22% Both group Psycho namic Interpersonal
Psychotherapy (gP and group CBT
(gCBT) improve int ersonal problems
(self-administered t s). Higher effects of
gPIP on patients w Cold/Distant





3 articles (211 BED
women)
——— ——— Aerobic and yoga e cises reduce binges
and BMI. Aerobic ex ise also reduces
depressive symptom CBT with aerobic
exercise and not CB lone reduces BMI.
CBBT with aerobic e cise is more effective




56 obese with BED 7 treatment;
60 follow-up
—— Weekly group CBT i roves eating behaviors,











7% IPT; 28% BWL;
30% CBTgsh
Comparing individ BWL, individual IPT
and group CBTgsh th IPT and CBTgsh
resulted in greater ge remission than
BWL. Moderators o utcome were
self-esteem and ea g psychopathology
(semi structured inte iew + self-administered
tests). CBTgsh can b first-line treatment
option, with IPT (or CBT) suitable for
patients with low se steem and high









23.25% Mindfulness + grou BT reduces binge
eating, dieting and y image dissatisfaction
both at end of treat nt and follow-up.
Qualitative interview ith 16 patients

























































Table 1 Summary of studies included in the review* (Continued)
Pharmacological
treatments
13 Arbaizar et al.,
2008 [74]
5 articles (528 BED
patients)
———— ——— Short-term treatment with topiramate
(50-600 mg/day) is more effective than
placebo in decreasing binges and weight in
both BN and BED. High number of withdrawals






with BED (15 bupropion;
15 sertraline)
6 treatment 0% Bupropion (150 mg/day) and (sertraline
200 mg/day) both reduced anxious-depressive
symptoms and binge frequency. Bupropion
more effective in reducing weight, with












28.4% Remission rates at 12-month follow-up of
3.7% for fluoxetine-only, 26.9% for CBT +
fluoxetine, and 35.7% for CBT + placebo.
None of the treatments produced significant
changes in BMI. CBT + fluoxetine and CBT +





51 obese with BED
(26 lamotrigine,
25 placebo)
4 44% Lamotrigine (236+/−150 mg/day) and
placebo performed similar on binge
reduction, eating pathology,
obsessive-compulsive symptoms, impulsivity,
and global severity of illness. Lamotrigine
was associated with a numerically greater
amount of weight loss and significant





40 BED with depression
(20 duloxetine;
20 placebo)
3 32.5% Duloxetine (mean 78.7 mg/day) superior to
placebo in reducing binge frequency,
weight and Clinical Global Impression-Severity
of Illness ratings for binge eating and
depressive disorders. Changes in BMI and
measures of eating pathology, depression





10 articles (234 BED
patients)
——— ——— Studying placebo response in BED, 38% of
patients show partial response and 26%
attain cessation. Lower baseline binge eating









6 35.7% Sertraline (100–200 mg/day) and fluoxetine
(40–80 mg/day) show similar efficacy on
binge frequency, weight loss and
psychopathology. Results were maintained







3 31% Duloxetine (60–120 mg) reduces binges,
eating impulsivity, depression, weight,














Table 1 Summary of studies included in the review* (Continued)
Marazzitti et al.,
2012 [75]
———— ——— ——— Topiramate (25-140 g/day) and zonisamide
(100-600 mg/day) s to suppress appetite





40 BED (20 acamprosate;
20 placebo)
2.5 38% Acamprosate (999 97 mg/day) improves
binge frequency, ssive-compulsiveness,
food craving and lity of life.
Double blind placebo
controlled trial
Mc Elroy et al.,
2011b [78]
12 BED 4 41.6% Sodium oxybate ( n 7.1 g/day) reduces






22 articles ——— ——— SSRIs are the most died drugs effective on
binge eating and p hiatric and weight
symptoms. Howev ost weight reductions
would not be cons ed clinically significant.
Duloxetine is effect n binge eating,
weight loss and de sive symptoms.
Reboxetine showed liminary reductions in
binge frequency an I. Topiramate is useful
in BED with obesity reasing weight and
obsessive-compulsiv ting pathology as well
as trait impulsivity. tat in combination
with CBT or dietary apy, enhances weight
loss and reduces bin eating. Zonisamide,
naltrexone (high do stimulants, and
glutamate-modulat agents show promises
for BED treatment. are not sufficient to
recommend pharm herapy as single first-line
therapy, however dr plays an important




14 articles (1279 patients) ——— ——— Pharmacotherapies e a clinical significance
over placebo on bin emission and weight
loss (statistically but clinically significant).
No data on long-te ffects. Combining
medications with p otherapy failed to
enhance outcomes. mising findings, albeit
modest, reported fo istat/topiramate +
CBT/BWL. Limited u of SSRI. Need for
additional large and ger studies.
Literature review





12 follow-up ——— Positive responde a brief CBT
intervention targe binge eating lost







24 follow-up 33% of eligible
patients
Binge eating and fectiveness
(self-administered s) correlate with


























































Table 1 Summary of studies included in the review* (Continued)
Faulconbridge et al.,
20134 [81]







41.2-17.6% to follow-up Surgery vs BWL group treatment
(20 weekly sessions + 10 fortnightly +
4 monthly sessions). Surgery participants
lost significantly more weight. Improvements
in mood and quality observed both in
surgery and BWL intervention, with no
differences at follow-up. Positive correlation
between weight loss and change in
depression scores. Weight loss at one time
point predicted depression score at next
time point, but depression score did not





(59 no ED, 36 BED),
49 BWL intervention





41.2-17.6% to follow-up At follow-up, surgically-treated participants
without BED lost 24.2% of initial weight,
compared with 22.1% for those with BED.
Both groups achieved clinically significant
improvements in several cardiovascular
disease (CVD) risk factors. BED participants
who received BWL lost 10.3% at 1 year.
Mean binges number fell sharply in both
BED groups at 1 year. Groups did not differ
significantly in BED remission rates or in
improvements in CVD risk factors.
Prospective
observational study
*Studies published from January 2008 to May 2014 and concerning adult patients with BED. Review or meta-analysis are cited in italics in the table.
**Description of the trial upon which the study is based has been reported elsewhere [85].













Amianto et al. BMC Psychiatry  (2015) 15:70 Page 14 of 22The concept of binge eating as “overeating without
compensatory behaviors” was introduced by Stunkard in
1959, and structured in the Nineties by Fairburn and
Spitzer as specific syndrome, mentioned in DSM-IV-TR
as a nosologic entity needing future definition [24]. Due
to an intense research activity providing solid evidence
on the differences between BED and Bulimia Nervosa
(BN), obesity and other ED-NOS [22,25], DSM-5 has re-
cently recognized BED as an autonomous disease, main-
taining diagnostic criteria which are consistent with the
previous edition, but reducing both frequency of the bin-
ging episodes and duration of eating behaviors required
to make the diagnosis [1].
In addition to diagnostic criteria included in DSM that
have proved clinical relevance and diagnostic efficacy in
several studies [22,26], also other psychopathologic basic
features have been outlined as relevant for treatment
planning and outcome. Overvaluation of shape and
weight is one of these conditions. It is present in 60% of
BED patients, a level which is significantly higher than
in non-BED obese patients, even though it is lower than
in AN and BN, where it is nearly universal [27]. Even if
this feature is present only in a subgroup of BED pa-
tients, and so it is not included among the official diag-
nostic criteria, it is related to higher psychosocial
impairment and worse quality of life [27]. BED patients
frequently refer to a constant polarization of thoughts
on weight control, diet and binge-avoidance, showing
worst eating control, higher fear of weight gain, and
higher body-shape dissatisfaction than non-BED obese
individuals, even though lower than in BN subjects
[16,21,25]. Overvaluation of shape and weight can be
thus considered either a diagnostic specifier or a dimen-
sional severity rate, with a primary relevance for diagno-
sis, treatment choice, global impairment and outcome,
and it can also be considered as a specific target for psy-
chological therapies [10,27,28].
Also food intake patterns are clinically important in
BED, as showed by the pathogenic model which has
been proposed for this disorder - inspired to the one
proposed by Fairburn and Cooper for BN. According to
this model, low self-esteem, body image-related, gener-
ates anxiety and negative emotions resulting in excessive
diet restrictions, in turn triggering bingeing [29]. Obese
individuals with BED may lack effective strategies for
managing negative emotions, and it has been hypothe-
sized that eating is undertaken as a strategy to regulate
or change negative emotions [30]. Recent studies, how-
ever, describe binge eating in BED as the possible result
of an immediate breakdown of emotion and impulse
regulation caused by sudden increases of negative affect
and tension, and/or rapid decrease of positive affect. In-
stead, it is unlikely that such behavior is consequent to
gradual accumulation of negative mood and subsequentimmediate relief as observed in BN [31]. Therapeutic
implications of these findings are represented by the de-
velopment of response-prevention strategies, such as the
acceptance of stressful events or the disclosure of mental
states. In contrast the suppression of unwanted behavior
during of high mental load may increase the probability
of bingering behavior [31].
In BED patients, daily distribution of food intake
shows peculiarities, unrelated to mood fluctuations,
which should be taken into account to process better
dietary and behavioral strategies to manage symptoms
and achieve therapeutic goals [32]. In fact, in BED pa-
tients they have been evidenced significantly more atyp-
ical eating behaviors, like dietary restraint or morning
under-eating, or recurrent overeating patterns like eating
double meals, or nocturnal eating and snack con-
sumption [18,32]. On the other hand, more frequent
breakfast consumption correlate with lower BMI and
more frequent meal consumption with reduced binge
eating [32].
The majority of binge episodes typically occur in less
than 2 hours, with a clinical and psychopathological im-
portance which is related to objective food intake [33].
Loss of control is a core feature associated with higher
depression, higher body dissatisfaction and poorer re-
lated quality of life [33]. The peculiar food choice that
patients make during binge episodes - e.g. fats, carbohy-
drates, sweets and snacks, − has been related to the
hypothesis of a “hedonic deprivation”, were eating im-
pulsiveness can be triggered by restrictions on palatable
foods during everyday life, even if at more recent find-
ings the presence of this clinical feature seems contro-
versial [33].
Linked to neurobiological mechanisms similar to those
of substance abuse, also “food dependence” is an import-
ant correlate of this finding, with dopamine, serotonin,
and endogenous opioids systems playing a role in this
regard [16]. Patients with BED show an increased reward
sensitivity towards food and increased rash-spontaneous
behavior, thus shaping a phenotype of obesity with in-
creased impulsiveness which should be identified and fo-
cused by specific psychological or pharmacological
treatment [16]. Recent studies underline indeed the im-
portance of genes on eating habits, identifying a herit-
able component of medium-high importance, referred to
the whole category of ED and with a gender-independent
transmission [34].
Regarding to psychopathological peculiarities and clin-
ical implications, BED should be also differentiated from
other obesity-related eating patterns characterized by
eating impulsiveness, not yet recognized as autonomous
syndromes but in a number of cases present in those af-
fected by BED [32]. Some these conditions are snacking
(introduction of small amounts of food throughout
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intense emotional states), and selective cravings (intense
desire and consuming of specific foods, e.g. sweet eating),
that should be considered as subtypes of binge-eating;




The treatment of BED, as for EDs in general, is influ-
enced by his etiological background, constituted of a
complex interaction of heritable, psychological and en-
vironmental factors that should be taken into account in
treatment planning [23,35]. Treatment choices should
then be multidisciplinary, suited to cope with symptoms
and comorbidities and also with the high drop-out rates
and the low maintenance of achieved results typical of
this disease [36,37]. Hallmarks of BED are in fact low
self-esteem experiences, weak therapeutic alliance, low
mastery and clarification experiences, in turn predicting
treatment dissatisfaction with and early discontinuation
of care [37]. To deal adequately with these features and
with the different core psychopathologic traits, the
therapeutic setting should be flexible and considering
exhaustively psychological and physical impairments
[23,35]. Moreover, the decision to seek treatment should
be preceded by enhancing patients’ motivation on their
condition [23]. The therapeutic project should be tai-
lored on the patient in accordance with protocol recom-
mendations and it should be frequently revised, on the
basis of the clinical needs [23]. Literature evidences con-
cerning the combination of different treatment strategies
at the same time are weak [35,36,38,39], instead it seems
more promising to provide stepped-care treatments with
rising levels of intervention intensity tailored on disease
severity [40-43].
Primary goal of BED treatment is to achieve abstin-
ence from binge eating, and afterward a sustainable
weight loss [44,45]. Nevertheless treatment should also
target the increase and maintenance of motivation, the
education to healthier eating and life styles, the modifi-
cation of dysfunctional thoughts and habits, the increase
of insight and abilities to deal with conflicts and negative
emotions, the treatment of physical and psychiatric co-
morbidities and relapse prevention [23,36,43,46]. The
therapeutic program should promote a stable reduction
of caloric intake and a permanent maintenance of
healthier eating and lifestyle habits, including instructing
patients to self-monitor their symptoms [36,43]. More
encouraging results can be obtained indeed with patients
trained to manage autonomously symptoms, mood fluc-
tuations, anxiety and stress levels [43,46]. This training
seems to be helpful in making the patients able to
recognize their needs, modify their thinking style, andfacilitate not only their cognitive but also their experien-
tial and intuitive learning [36,43,46]. To enhance efficacy
on weight loss, which is not a primary outcome of BED
treatment but a factor associated with consistent impair-
ment and comorbidity, some evidences support the
association of pharmacological and psychotherapeutic
treatments to behavioral interventions, based on weight
and diet monitoring, and borrowed by general obesity
management [35,36,38,40,47].
It can be useful to set an adequate treatment plan as
soon as possible, because early responses to treatment
are important from a prognosis standpoint [43,45,48]. That
can be favored by treatment specificity and stepped-care
treatments, providing periodic re-evaluations addressing
non-responders to more specialized interventions [41-43].
Binge abstinence should be pursued at the very begin-
ning of treatment, also because the achievement of this
goal per se in some cases leads to significant weight loss
[44]. Nevertheless in most cases treatment should not
target weight loss at first, but weight stabilization
[44,49]. Some studies in fact show frequent and substan-
tial weight gain one year prior treatment seeking, pro-
viding an important element to interpret the modest
weight losses typically reported in literature [49,50]. Also
weight regain is a critical target for BED patients, who
report marked weight fluctuations and spend much time
trying to lose weight [50]. The poor weight loss showed
in literature studies may than be re-interpreted at the
light of a successful weight stabilization, and an effective
prevention of further weight regain [49,50].
Behavioral interventions
Behavioral treatments (BWL), focused on diet and life-
style modification, and borrowed by obesity treatment,
have frequently been proposed as useful basic inter-
ventions for BED treatment that showed some appre-
ciable results which are comparable to more complex
therapies, in patients with low associated psychopath-
ology [44,51].
Diet therapy is essential to promote weight loss, and
for this reason it is object of great attention among BED
patients who are characterized by high body dissatisfac-
tion [21] and higher overvaluation of body weight and
shape, which generally represent negative outcome pre-
dictors [10]. Moreover it should be reminded that, even
if body weight is not directly linked with disease severity,
it is strictly correlated with several medical comorbidi-
ties [4]. Furthermore, body weight heavily influences
perceived wellness, mood and self-esteem in those af-
fected by BED and, consequently, binge vulnerability
itself [27,18]. On the other hand binge episodes are re-
currently triggered by excessive dietary restraint which
can be enacted by BED subjects to reduce body weight
faster [18,29]. Therefore, prescribed caloric restrictions
Amianto et al. BMC Psychiatry  (2015) 15:70 Page 16 of 22in BED should be moderate, and a normal or hypocalo-
ric diet seems to be the best strategy to prevent bingeing
[40,46]. Weight loss anyway should be pursued only
after binge reduction or stabilization and the attempt to
lose considerable weight in a short time should be dis-
couraged, because of the increased risk of weight regain
[49,51,52]. Poor compliance to diet should not be
blamed but it should be addressed instead when plan-
ning the nutritional scheme, because only its manage-
ment could make it possible to reach a stable control
over eating behaviors [40]. It is recommended not to to-
tally exclude any food choices; it could be more useful
instead to encourage patients to moderate their food in-
takes according to individual needs [40].
Physical activity, coupled to a balanced diet, is another
basic factor for weight loss, both for its direct action on
fat consumption and its inhibitory action on excessive
food intake [47]. It also helps maintaining goals reached
with diet, and it improves mood and general health, low-
ering clinical comorbidities of BED [47]. However, due
to frequently compromised health conditions of BED pa-
tients, physical activity should be established gradually
and under close medical supervision [47]. In conclusion,
it must be anyhow underlined that, even if BWL therap-
ies have showed in some studies a relevant usefulness,
especially on weight loss [35,36,44,52], their efficacy in
BED remission is lower than more specific intervention
like psychotherapies, and that their dropout rates are
higher [43,46,52].
Psychoeducational interventions
Psychoeducational treatments for BED are purposed to
inform patients about different aspects and correlates of
their disease, in order to promote a deeper comprehen-
sion of their condition and thus to increase the possibil-
ities to manage it [53,54]. These interventions give
information about core topics like the factors that pre-
dispose, trigger and maintain eating impulsiveness, nega-
tive effects of overweight and unbalanced or restrictive
diets, and most effective methods of weight regulation
[53]. Treatments are focused on plain symptoms explan-
ation, without adopting strategies to influence uncon-
scious or cognitive maintaining factors at a deep level,
unlike to what occurs in psychotherapies [53,54].
Advantages of these treatments are that they can be
administered by low-specialized personnel, they can be
easily manualized, and they can be structured in weekly
group meetings of limited duration [53]. Patients are
taught to self-monitor food intake and are informed
about factors that trigger binges and about correct life-
styles, sustainable in time [53,54]. They are also ex-
plained the pathogenic mechanisms of the disease and
about strategies suitable to establish a stable change.
Interventions are focused on lifestyle modification topromote a general improvement of health and quality of
life, rather than on weight loss itself [53,54].
These interventions have showed a preliminary effi-
cacy on binge reduction and eating impulsivity [53,54],
even if effects on body dissatisfaction, anxiety, depressive
symptoms and weight loss are still controversial [54].
Among patients who undergo this kind of intervention,
higher eating impulsivity correlates with higher drop-out
rates, and this suggests that more specific and intensive
intervention should be suitable for patient with heavier
psychopathology [53].
Considering these preliminary findings, psychoeduca-
tional interventions could constitute useful baseline
therapies that constitute a useful starting point for more
complex treatments, and that can show efficacy compar-
able to more complex interventions on less severe cases.
Studies with randomized control groups, are still needed
to support this recommendation [53].
Psychotherapies
According to literature data, also with regards to sys-
tematic reviews and meta-analysis, psychotherapies
are the most validated and effective treatments for
BED [36,38,43].
Cognitive-Behavioral Therapies (CBT) are the most
evaluated and developed psychological intervention for
treating BED [36,38]. The focus is the etiological basis of
bingeing and its relation with a self-esteem excessively
dependent form body shape [10,38]. The most widely
used CBT models are adaptations of those developed for
BN, paying close attention to weight loss and taking into
account the lower restriction levels and the lower cogni-
tive distortions of BED compared to BN [38,43].
CBT is a practical and adaptable intervention, with
setting and duration that can be tailored on clinical
needs and the possibility of being carried out independ-
ently or in combination with other pharmacological or
BWL approaches [36,38-40,47]. Anyway evidences sup-
porting combination treatment are still limited and con-
troversial, while CBT have yet showed high efficacy
when administered alone, with BED remission rates
around 50-60% [9,52,55]. Even if in BED CBT failed to
show higher immediate binge reduction when compared
to BWL interventions at short-time observations, it
seems to overcome these therapies especially over long
periods of time, improving quality of life, and reducing
drop-out rates [44,52]. Long term effects of CBT ap-
proaches include, in fact, a gradual normalization of eat-
ing patterns and reduced relapse occurrence, these
effects are coupled with the improvement of disinhib-
ition, hunger, negative feelings and perceived global
health [51,56,57]. Unfortunately, evidences about effects
on weight reduction are still limited and of unclear clin-
ical significance [9,36,52]. Also data about advantages of
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needs further deepening [40,52]. Individual or group set-
ting have showed a similar efficacy, maintained at 3 years
follow-up [43,57]. Instead long-term versus short-term
interventions have showed comparable results on pa-
tients with favorable outcome predictors, but it was evi-
denced an higher efficacy of long-term treatment in
patients with higher psychopathology [58].
Among outcome predictors, literature data have
showed a consistent importance of a rapid response to
treatment, of lower overeating frequency, and of lower
general psychopathology levels, but also of higher social
embedding and higher openness [44,59].
CBT-based treatments have showed their usefulness
also when administered in self-help setting, thus offering
another valid first-line treatment option which is more
efficient than treatment as usual [60], superior to BWL-
based self-help models [43], and without contraindica-
tions for patients with comorbid conditions [61]. From a
cost-effectiveness standpoint self-help interventions con-
stitute a valid first-line option while more specific ther-
apies like IPT or CBT could be used in a more specific
way for patients with higher eating psychopathology and
lower self-esteem [43]. Self-help interventions can be
guided by either therapists trained in EDs (who can run
all sessions or only some), or not ED-specialized thera-
pists or managed by patients only [62,63]. The presence
of a trained therapist who leads the group sessions gives
a better short-term outcome and less group contrast,
but significant differences have not been showed so far
as regards outcomes between guided and self-help
groups at follow-up [62,63]. Some preliminary studies
have also evaluated the efficacy of Internet guided self-
help programs, but their efficacy is still debated [62].
Dialectic-Behavioral Therapy (DBT) is another psycho-
therapeutic approach that has proved its efficacy in BED;
it is more focused on emotion regulation and stress tol-
erance than CBT [43]. This therapy showed to be effect-
ive in binge reduction and in lowering concerns about
food and body shape similarly to CBT, but it has not
provided clear results on weight loss, depression, or anx-
iety [64,65]. It seems to be effective also when negative
outcome predictors occur as earlier age at binges onset
and higher personality disturbances [7,48]. Some prelim-
inary findings show DBT to be effective also when ad-
ministered as a self-help intervention, a suitable low-
intensity treatment option for BED [66].
Another evidence-based psychological treatment is
Interpersonal Psychotherapy (IPT). This technique fo-
cuses on personal relations and role transitions that
could have a predisposing and maintaining role in EDs,
in order to achieve better social interactions and to cope
with interpersonal conflicts [41-43]. Even if it doesn’t
focus directly eating symptoms, it can be useful becauseit targets a specific area of impairment in BED patients
[42]. This disease in fact often emerges in adolescence
[4], in a context of interpersonal and maturation difficul-
ties, and its maintenance over the years can be related to
dysfunctional relational styles that triggers depression,
anxiety, and anger feelings in turn underlying eating im-
pulsiveness [11]. It has been hypothesized that IPT, also
administered in a psychodynamic framework, with add-
itional focus on cyclical dysfunctional relational patterns,
could be particularly effective on individuals for whom
negative moods act as major triggers for bingeing or
with cold/distant attachment style [41]. It appears in any
case effective on depression and psychosocial discomfort
[41,43]. It has been observed that CBT and IPT have
comparable efficacy in binge reduction, both at the end
of therapy and at one-year follow-up, with a significant
reduction of psychiatric comorbidities and in some cases
a significant decrease in body weight. Therapeutic re-
sults are stable at a 4-year follow-up [67,42,43].
All in all, psychotherapeutic approaches to BED, mostly
based on CBT models, are useful first-line treatments, even
more than pharmacological approaches [36,43].
Pharmacological treatment
Pharmacological therapy in BED is specifically focused
on the reduction of eating impulsiveness, binges and
negative feelings, constituting a co-cause and a compli-
cation of eating symptoms. It has been noticed a statisti-
cally significant drug action on short-term binge
remission and also on weight loss, although this does
not hold significant at longer follow-up [36,38]. Unfortu-
nately, few data exist on long-term efficacy of pharmaco-
therapy as stand-alone treatment for BED, and in some
studies combined treatment of drugs and psychotherapy
interventions failed to enhance outcome significantly
[55,35]. Most treatment options currently used in BED
have at first demonstrated their efficacy on binge re-
duction in BN, but non-psychoactive drugs, borrowed
from obesity treatment, are also in use in selected
cases or in combination with other treatments like
psychotherapies [68].
As an additional element supporting the specificity of
BED diagnosis, it is noteworthy that psychopharmaco-
logical therapy showed higher efficacy in BED than in
non-BED obese population and that placebo response
was consistent with the one observed in other major
psychiatric diseases [69].
Antidepressants are the most widely studied and ap-
plied medications in BED treatment, showing efficacy on
eating impulsiveness and eating and general psychopath-
ology, but also on anxiety and depressive symptoms,
with supposed secondary positive effects on eating im-
pulsiveness due to lowering of negative affects that trig-
ger binges [36,38].
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showing side effects on weight and hunger, and it is bet-
ter to choose pro-anorectic antidepressants molecules to
improve treatment compliance. It is for this reason that
tricyclic antidepressants are not commonly used in EDs,
while selective serotonin reuptake inhibitors (SSRIs) are
preferred given their anti-impulsive action [68]. On the
other hand, when eating impulsiveness is not related to
a specific psychopathology, it is possible to evaluate in
selected cases the use of medications that act directly on
hunger regulation and food absorption, without influen-
cing mood [36].
SSRI at high doses have showed efficacy on binge
reduction and associated psychopathology, with some
limited evidences of effectiveness on weight loss,
which are of questionable clinical significance [38,68].
Even if differences in long-term action among SSRI
still have to be clearly established, fluoxetine is the
most widely studied and prescribed because of its
registration for BN [70]. It proved significant efficacy
above placebo on binge reduction, weight loss and
mood improvement [69,70], but uncertain clinical
relevance and consistently lower effects than CBT,
also in combination treatments [55,70]. Sertraline
and fluvoxamine have showed similar results to flu-
oxetine, while citalopram and paroxetine are scarcely
implied because of their side-effects on hunger and
weight gain [68,70,71].
Duloxetine in some initial studies was reported to reduce
hunger and binges and promote weight loss [72,73], even
the current body of evidence is still lacking [68].
Reboxetine showed significant reductions in binge fre-
quency and BMI in a small preliminary open-label trial
of 12-week [67].
Bupropion showed effectiveness on binge eating, anx-
iety, and depressive symptoms in a single study, with
better efficacy than sertraline on sexual side-effects and
weight loss [71].
Among anti-epileptic drugs, topiramate reduced hun-
ger, promotes weight loss, and can obtain a significant
reduction in daily and weekly binge episodes and impul-
sivity. Nevertheless, it has not showed efficacy on psy-
chopathological distress or depressive symptoms, while
its results on weight loss are still debated [68,74,75].
Lamotrigine showed preliminary efficacy on weight loss
and metabolic dysfunction but without results on gen-
eral and eating psychopathology, and global severity of
illness [76]. Also zonisamide seems to be able to sup-
press appetite and increase eating control, leading to
BMI reduction [75,68].
Psychostimulants like atomoxetine, naltrexone and
glutamate-modulating agents seems to be promising
treatments, acting on binge reduction and weight loss
when compared to placebo [68].Acamprosate was associated at endpoint analysis with
improvements on binge frequency, food craving and
quality of life compared to placebo [77]. Sodium oxibate,
in a small sample without control group, show reduc-
tions of binge episodes, related psychopathology, and
also weight loss [78].
In conclusion, current literature data evidence still un-
clear efficacy of pharmacological treatments for BED.
Nevertheless they are widely applied in clinical practice
and play an important role in BED management [68].
Even though these treatments produced a significant re-
duction of binges and eating impulsiveness, and in some
cases also weight losses, clinical relevance of these modi-
fications is still doubtful and limited by small sample
sizes, high dropout rates, and short follow-up times
[38,68]. Also the usefulness of pharmacotherapy as associ-
ation treatment, with the purpose to enhance effects of
BWL or psychotherapies, is still highly unclear, with scarce
data and discordant findings at support [35,36,38,68].
Surgical interventions
Bariatric surgery is a recommended treatment for severe
obesity (BMI ≥40 or BMI ≥35 with comorbid conditions)
according to current guidelines [79], while it is not men-
tioned among evidence-based BED treatments [80].
However obese individuals with BED frequently experi-
ence weight-related impairments in mood and quality of
life, which improve with weight loss [19]. This improve-
ment of wellness and quality of life acts as a protective
factor against binge vulnerability, making bariatric sur-
gery a useful option in severe obesity linked to BED [81].
The high disability linked to BED itself, coupled with the
difficulty to achieve a stable weight loss with traditional
behavioural interventions, causes an elevate BED preva-
lence in surgery candidates, ranging from 5% to 50%
[82]. On the other hand, an ED diagnosis was once
considered a major contraindication to bariatric sur-
gery. This limitation has been reduced over time and
bariatric surgery interventions can now be suitable
for selected BED patient, even if the extent of weight
loss depends on the presence of binge episodes after
the intervention [83].
Faulconbridge and coworkers [81] explored the effects
of bariatric surgery in BED patients with severe obesity,
trying to enlighten if observed improvements are due to
weight loss itself or to additional aspects of treatment,
such as therapeutic support or acquisition of cognitive-
behavioral skills. They found significant improvements
in mood and quality of life at follow-up both in patients
who undergo surgery and in controls enrolled in a BWL
intervention, but they evidenced no differences be-
tween the groups at month 12. Nevertheless, bariatric
surgery showed a significantly higher efficacy on weight
reduction [81].
Amianto et al. BMC Psychiatry  (2015) 15:70 Page 19 of 22Wadden and coworkers [82] found no relevant differ-
ences in post-surgical weight loss between patients with
and without BED, higher than weight loss obtained with
lifestyle modifications at 1 year follow-up. The mean
number of binge eating days fell sharply both with sur-
gery and with BWL interventions [82].
Nevertheless, due to the required changes in patients’
lifestyle and the high economic costs of bariatric surgery,
candidates should be carefully screened. These treat-
ments should then be proposed after a careful evaluation
of psychological conditions, and a psychiatric and psy-
chological assessment before and after surgical interven-
tion is recommended. In fact, bariatric surgery or
lifestyle modification treatments led to comparable re-
sults on mood and quality of life at the 1-year follow-up
[84]. To achieve good outcome it is fundamental to pro-
vide the patient with a framework of nutritional-
metabolic and psychological rehabilitation, focused on
empowering and stimulating an active and informed col-
laboration [84]. In the first months after surgery, pa-
tients with BED who present a high gastric capacity
before intervention can show an initial weight loss even
higher than usual and complete binges remission [82].
However binge behaviors tend to resume partially after
12 months follow-up [82]. Binge recurrence may occur
when patients learn to manage their new condition,
and to circumvent eating limitations caused by the
intervention – e.g. replacing classical binge episodes
with great caloric intakes in liquid or semi-liquid
forms [82,84].
It is noticeable from these data that a stable binge con-
trol, obtained with pharmacological o psychological
intervention, should be a primary outcome to be pur-
sued in BED patients that undergo bariatric surgery [83].
It predicts better prognosis which is frequently not
significantly different from that of non–BED obese indi-
viduals [81,82,84].
Conclusions
Despite its recent inclusion in DSM-5 as an autonomous
disease, further research is needed on BED diagnosis and
treatment strategies, through larger samples and longer
follow-up times [36]. Although present diagnostic cri-
teria has showed their empirical consistency other core
psychopathologic features like body and weight over-
valuation may be of clinical and prognostic relevance
[27]. Binge stability and spontaneous remission rates
should be better explored [9], deepening the identifica-
tion of prognostic factors able to address treatment
choices and to favor more specific and cost-effective in-
terventions [36,37]. Also the importance of comorbidi-
ties and weight maintenance in treatment adherence and
remission should be extensively investigated because of
its influence on prognosis and treatment [18].Multidisciplinary treatment choices seems to emerge
as the best treatment strategy for long-term manage-
ment of this disease, with primary goals on binge abstin-
ence and at a second time a sustainable weight loss
[44,45]. Nevertheless treatment should also target sec-
ondary outcomes as the increase and maintenance of
motivation, the reduction of drop-out rates and the
management of relapses [43,46]. Further studies are
however required to enlighten most promising treatment
combinations, considering evidences of limited useful-
ness of combining different treatments at the same time
[35,36,38,39]. Stronger literature support stepped-care
treatments, with a rising intensity of intervention tai-
lored on disease severity [40-43].
Psychotherapeutic approaches to BED, mostly based
on CBT models, are recommendable as first-line treat-
ments with the wider evidences of efficacy also at long-
term follow-up, but still unclear results on weight loss
[36]. Otherwise simpler and cheaper interventions
like BWL treatments, psychoeducational interventions
and self-help treatments have showed significant effi-
cacy in patients with lower disease severity and less
comorbidity [43,44,53].
Drug therapy, especially SSRIs can be useful in lower-
ing eating impulsivity and improving psychiatric comor-
bidities [36]. Unfortunately, long-term efficacy of
pharmacotherapy as a stand-alone treatment for BED
needs further research, as well as long-term effects
of integrated treatment combining drugs and psycho-
therapy [36,38].
Even if bariatric surgery is not a recommended treat-
ment for BED according to current guidelines [79], its
clinical relevance in BED coupled with severe obesity
deserves more careful clarifications [80].
In summary, even if literature data about BED diagno-
sis and treatment are gradually deepening and improving
in detail and significance, further studies, especially lit-
erature review and meta-analysis, are still required with
major regard to long term outcomes, stepped care
treatment, improving of weight loss (also with surgery
treatment) and lowering dropout rates.
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